The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity
- PMID: 3520317
- DOI: 10.1056/NEJM198606193142502
The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity
Abstract
We conducted a randomized controlled trial to determine whether intensive multi-agent adjuvant chemotherapy improves the chances of relapse-free survival in patients with nonmetastatic high-grade osteosarcoma of the extremity, as compared with concurrent controls. After undergoing definitive surgery, 36 patients were randomly assigned to adjuvant chemotherapy or to observation without adjuvant treatment. At two years the actuarial relapse-free survival was 17 percent in the control group, similar to that found in studies before 1970, and 66 percent in the adjuvant-chemotherapy group (P less than 0.001). Similar results were observed among 77 additional patients who declined to undergo randomization but who elected observation or chemotherapy. We conclude that the natural history of osteosarcoma of the extremity has remained stable over the past two decades, that adjuvant chemotherapy increases the chances of relapse-free survival of patients with high-grade osteosarcoma, and that it should be given to all such patients.
Similar articles
-
[Preoperative and postoperative chemotherapy of osteogenic sarcoma of the limbs in children].Med Clin (Barc). 1996 Jun 29;107(5):161-4. Med Clin (Barc). 1996. PMID: 8758673 Spanish.
-
Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: is a good response to preoperative treatment an indication to reduce postoperative chemotherapy?Chemioterapia. 1986 Apr;5(2):140-3. Chemioterapia. 1986. PMID: 3458546
-
Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):505-11. doi: 10.1016/j.ijrobp.2006.08.072. Epub 2006 Nov 21. Int J Radiat Oncol Biol Phys. 2007. PMID: 17118571
-
[Progress and stagnation in chemotherapy protocols for primary osteosarcoma].Ann Med Interne (Paris). 2003 Feb;154(1):12-24. Ann Med Interne (Paris). 2003. PMID: 12746655 Review. French.
-
The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the Italian Rizzoli experience. Impact on the future.Cancer Treat Res. 2009;152:275-87. doi: 10.1007/978-1-4419-0284-9_14. Cancer Treat Res. 2009. PMID: 20213396 Review.
Cited by
-
Overexpression of pyruvate kinase M2 predicts a poor prognosis for patients with osteosarcoma.Tumour Biol. 2016 Nov;37(11):14923-14928. doi: 10.1007/s13277-016-5401-7. Epub 2016 Sep 19. Tumour Biol. 2016. PMID: 27644251
-
Guideline for Limb-Salvage Treatment of Osteosarcoma.Orthop Surg. 2020 Aug;12(4):1021-1029. doi: 10.1111/os.12702. Epub 2020 Jul 6. Orthop Surg. 2020. PMID: 32633103 Free PMC article.
-
Exploring the Impact of Exosomal Cargos on Osteosarcoma Progression: Insights into Therapeutic Potential.Int J Mol Sci. 2024 Jan 1;25(1):568. doi: 10.3390/ijms25010568. Int J Mol Sci. 2024. PMID: 38203737 Free PMC article. Review.
-
L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer.Am J Cancer Res. 2016 Feb 15;6(3):677-89. eCollection 2016. Am J Cancer Res. 2016. PMID: 27152244 Free PMC article.
-
Review of Osteosarcoma and Current Management.Rheumatol Ther. 2016 Dec;3(2):221-243. doi: 10.1007/s40744-016-0046-y. Epub 2016 Oct 19. Rheumatol Ther. 2016. PMID: 27761754 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
